Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.
作者信息
Abu-Elmagd K M, Fung J, Draviam R, Shannon W, Jain A, Alessiani M, Takaya S, Venkataramanan R, Warty V S, Tzakis A
机构信息
Department of Surgery, University of Pittsburgh, PA 15213.
出版信息
Transplant Proc. 1991 Dec;23(6):2767-70.
Abstract
摘要
相似文献
1
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.肝移植中FK 506的4小时与24小时静脉输注
Transplant Proc. 1991 Dec;23(6):2767-70.
2
Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity.肝移植后每日三次给予他克莫司（FK 506）以将肾毒性和神经毒性降至最低。
Transplant Proc. 2003 Nov;35(7):2787-8. doi: 10.1016/j.transproceed.2003.09.009.
3
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.肝移植患者FK 506治疗策略：移植肝功能的影响
Transplant Proc. 1991 Dec;23(6):2771-4.
4
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.FK506治疗难治性肾移植排斥反应：来自肝移植的经验教训。
Clin Transplant. 1996 Aug;10(4):323-32.
5
6
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.肝移植后难治性排斥反应从环孢素转换为基于FK 506的免疫抑制治疗成功的预后因素。美国多中心FK 506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
7
Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.肝移植患者转换为缓释他克莫司后的疗效表明，在特定队列中可能会有良好的结果。
Liver Transpl. 2015 Jan;21(1):29-37. doi: 10.1002/lt.24022.
8
Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
Transplant Proc. 2001 Feb-Mar;33(1-2):1339-40. doi: 10.1016/s0041-1345(00)02500-8.
9
10
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Transplant Proc. 1996 Apr;28(2):1008-10.
引用本文的文献
1
Immunosuppression in Lung Transplantation.肺移植中的免疫抑制。
Handb Exp Pharmacol. 2022;272:139-164. doi: 10.1007/164_2021_548.
2
Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation.肺移植术后早期每日两次大剂量静脉注射他克莫司的长期给药
Ann Transplant. 2017 Aug 11;22:484-492. doi: 10.12659/aot.904225.
3
Immunosuppression and allograft rejection following lung transplantation: evidence to date.肺移植后免疫抑制和移植物排斥：现有证据。
Drugs. 2013 Nov;73(16):1793-813. doi: 10.1007/s40265-013-0136-x.
4
The current status of hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的现状
Clin Transpl. 1995:145-70.
5
Adverse effects of FK 506 overdosage after liver transplantation.肝移植后FK 506过量的不良反应。
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
6
7
Recent advances in hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的最新进展。
Clin Transpl. 1993:137-52.
本文引用的文献
1
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
2
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
Transplant Proc. 1991 Dec;23(6):2780-2.
3
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.移植功能对FK506血药浓度、剂量及肾功能的影响，尤其涉及肝脏。
Transplantation. 1991 Jul;52(1):71-7. doi: 10.1097/00007890-199107000-00015.
4
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.口服给药后FK 506的药代动力学：FK 506与环孢素的比较。
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
5
6
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.肝功能不全和T管夹闭对FK 506药代动力学及谷浓度的影响。
Transplant Proc. 1990 Feb;22(1):57-9.
7
Pharmacokinetics of FK 506: preclinical and clinical studies.FK506的药代动力学：临床前和临床研究。
Transplant Proc. 1990 Feb;22(1):52-6.
Zotero 插件